Can I read Abemaciclib in HR-positive Breast Cancer on EtoBox?

Abemaciclib in HR-positive Breast Cancer by Nicole is a document available to read on EtoBox.

What is Abemaciclib in HR-positive Breast Cancer about?

The document provides an overview of three kinase inhibitors—Abemaciclib, Palbociclib, and Ribociclib—used in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer, detailing their indications, dosing, and common adverse reactions. Each drug is indicated for specific combinations with aromatase inhibitors or fulvestrant, with varying dosing regimens and safety considerations. Common adverse reactions include neutropenia, diarrhea, and nausea, with additional monitoring for hepat

Author

Nicole

Language

EN